John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$172M |
| 2 |
Johnson & Johnson
JNJ
|
+$161M |
| 3 |
American Express
AXP
|
+$161M |
| 4 |
Apple
AAPL
|
+$156M |
| 5 |
Emerson Electric
EMR
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$172M |
| 2 |
AGN
Allergan Inc
AGN
|
+$139M |
| 3 |
Wynn Resorts
WYNN
|
+$111M |
| 4 |
AbbVie
ABBV
|
+$94.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.92% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 10.9% |
| 4 | Healthcare | 10.87% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
CALL
Canadian Pacific Kansas City
CP
$83.2B
| $2.38M | 0.01% |
+65,000
| New | +$2.4M |
|
|
SEM
1077
DELISTED
Select Medical
SEM
| $2.37M | 0.01% |
297,108
+21,863
| +8% | +$163K |
|
1078
Cousins Properties
CUZ
$4.94B
| $2.37M | 0.01% |
79,314
-220,420
| -74% | -$6.81M |
|
|
TBRG
1079
DELISTED
TruBridge
TBRG
| $2.36M | 0.01% |
43,531
+34,819
| +400% | +$1.91M |
|
1080
CEMIG Preferred Shares
CIG
$5.58B
| $2.36M | 0.01% |
1,132,224
-2,012,749
| -64% | -$4.39M |
|
1081
Sixth Street Specialty
TSLX
$1.8B
| $2.36M | 0.01% |
137,132
+50,385
| +58% | +$885K |
|
|
WCG
1082
DELISTED
Wellcare Health Plans, Inc.
WCG
| $2.35M | 0.01% |
+25,723
| New | +$2.15M |
|
1083
Hexcel
HXL
$7B
| $2.34M | 0.01% |
+45,586
| New | +$2.09M |
|
1084
Neurocrine Biosciences
NBIX
$15.6B
| $2.34M | 0.01% |
+58,898
| New | +$2.11M |
|
1085
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.07B
| $2.34M | 0.01% |
127,794
+48,862
| +62% | +$777K |
|
1086
Provident Financial Services
PFS
$3.07B
| $2.33M | 0.01% |
125,003
+73,741
| +144% | +$1.33M |
|
|
PLKI
1087
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
| $2.32M | 0.01% |
38,827
-24,672
| -39% | -$1.47M |
|
1088
Ribbon Communications
RBBN
$365M
| $2.32M | 0.01% |
294,283
+286,619
| +3,740% | +$4.72M |
|
|
EGOV
1089
DELISTED
NIC Inc
EGOV
| $2.32M | 0.01% |
131,122
+568
| +0.4% | +$9.66K |
|
|
PINC
1090
DELISTED
Premier
PINC
| $2.31M | 0.01% |
61,477
-30,930
| -33% | -$1.08M |
|
1091
CALL
American Electric Power
AEP
$66.4B
| $2.31M | 0.01% |
+41,000
| New | +$2.43M |
|
|
KRA
1092
DELISTED
Kraton Corporation
KRA
| $2.29M | 0.01% |
113,483
+21,743
| +24% | +$430K |
|
1093
Fortuna Silver Mines
FSM
$3.61B
| $2.29M | 0.01% |
605,274
+222,097
| +58% | +$979K |
|
1094
Teekay
TK
$1.17B
| $2.29M | 0.01% |
49,182
-100,984
| -67% | -$4.52M |
|
1095
Biogen
BIIB
$32.2B
| $2.28M | 0.01% |
5,402
-7,674
| -59% | -$3.02M |
|
|
DNB
1096
DELISTED
Dun & Bradstreet
DNB
| $2.28M | 0.01% |
+17,752
| New | +$2.22M |
|
1097
Mercury Systems
MRCY
$5.38B
| $2.27M | 0.01% |
145,865
+31,668
| +28% | +$500K |
|
1098
TriMas Corp
TRS
$1.42B
| $2.26M | 0.01% |
+92,251
| New | +$2.18M |
|
1099
State Street Industrial Select Sector SPDR ETF
XLI
$33.2B
| $2.26M | 0.01% |
+40,550
| New | +$2.28M |
|
|
ORBK
1100
DELISTED
Orbotech Ltd
ORBK
| $2.26M | 0.01% |
140,928
+27,161
| +24% | +$431K |
|
Similar funds
John Overdeck's Q1 2015 Portfolio in Review
As of Q1 2015, John Overdeck held 3,174 positions worth $21.5B, up 19% from $18.1B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
John Overdeck deployed $3.03B of net new capital in Q1 2015, opening 981 new positions and adding to 805 existing holdings. Its largest new stake was Intel: 5,084,443 shares worth $159M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $94.4M trimmed.
- John Overdeck's largest Q1 2015 buy was Intel: 5,084,443 shares worth $159M.
- John Overdeck added most to Johnson & Johnson in Q1 2015, an estimated $161M increase.
- John Overdeck's biggest Q1 2015 reduction was AbbVie, cutting an estimated $94.4M.
- John Overdeck fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $172M.
- John Overdeck's ten largest holdings make up 7.3% of its $21.5B portfolio in Q1 2015.
- John Overdeck opened 981 new positions and closed 576 in Q1 2015.
- John Overdeck's portfolio value rose 19% quarter-over-quarter to $21.5B.
Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.